spacer
home > pmps > autumn 2003 > future cold chain technology for the 21st century: the 'blue sky' idea
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Future Cold Chain Technology For The 21st Century: The 'Blue Sky' Idea

Cold chain distribution in relation to the pharmaceutical and biotech industry has often been perceived as the less glamorous and 'latent' service that is allied to this business sector. However, the importance of ensuring that a temperature-sensitive medicinal product reaches the end-user without compromising integrity and efficacy is paramount. It is therefore not strange that awareness, comprehension and advances are continually on the increase due to the pro-active actions of service providers, that is, manufacturers of designed insulated shipping systems and part/fully active shipping systems. Although reaction is based on fulfilling more stringent customer requirements to design solutions that can withstand the most extreme of conditions, there are other contributing, key factors that have come into the spotlight over recent years which are promoting industry response.

Firstly, according to the Biotechnology Industry Organisation 2002, there are currently 350 biotech products and vaccines at various phases within the clinical trials process, and a large proportion are considered to be temperature-sensitive. It is estimated that the growth of such products is in the region of 15 per cent per year.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Robert Kayum, Application Support Manager at Envirotainer

Robert Kayum is Technical Sales Support Manager at Envirotainer. He previously worked for Laminar Medica, manufacturers of insulated shipping systems for the pharmaceutical and biotechnology industry, where he obtained widespread experience in manufacturing. At Laminar Medica, Robert assisted in building up the technical department, gaining a reputation for research, design, testing and consultancy of validated shipping systems for various pharmaceutical and biotechnological companies worldwide. He studied Applied Sciences at foundation level in Richmond upon Thames and won a place at Kings College to read Pharmacology.

spacer
Robert Kayum
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement